Dry Eye Disease
Showing NaN - NaN of 8
Dry Eye Disease Trial in United States (0.02% Betamethasone Sodium Phosphate, 0.04% Betamethasone Sodium Phosphate, Placebo)
Completed
- Dry Eye Disease
- 0.02% Betamethasone Sodium Phosphate
- +2 more
-
Dothan, Alabama
- +27 more
Nov 9, 2022
Dry Eye Disease, Sjögren Syndrome Trial in United States (Tivanisiran sodium ophthalmic solution, Vehicle ophthalmic solution)
Recruiting
- Dry Eye Disease
- Sjögren Syndrome
- Tivanisiran sodium ophthalmic solution
- Vehicle ophthalmic solution
-
Birmingham, Alabama
- +38 more
Sep 15, 2022
Dry Eye Disease, Kerato Conjunctivitis Sicca Trial in United States (Pilocarpine Ophthalmic Topical Cream, Dose 1, Pilocarpine
Completed
- Dry Eye Disease
- Kerato Conjunctivitis Sicca
- Pilocarpine Ophthalmic Topical Cream, Dose 1
- +3 more
-
Chandler, Arizona
- +18 more
Aug 26, 2022
Dry Eye Disease Trial in United States (SURF-100 (Combination of 0.3% Mycophenolic Acid and 0.01% Betamethasone Sodium
Completed
- Dry Eye Disease
- SURF-100 (Combination of 0.3% Mycophenolic Acid and 0.01% Betamethasone Sodium Phosphate)
- +6 more
-
Phoenix, Arizona
- +39 more
Apr 10, 2022
Dry Eye Disease Trial in United States (P-321 Ophthalmic Solution, P-321 Ophthalmic Solution )
Terminated
- Dry Eye Disease
- P-321 Ophthalmic Solution
- P-321 Ophthalmic Solution placebo
-
Artesia, California
- +6 more
Sep 12, 2018